Allink Biotherapeutics

Shanghai, China

Collaborations & Partnerships- R&DCollaborations & Partnerships-LicensingCollaborations & Partnerships-ManufactureDrug DeliveryProprietary Research & Manufacture Basic Listing

C-Score

35%

Developing Profile

Company Details

Address 2nd Floor, South Building, No. 2966,, Jinke Road, Pudong New Area,, Shanghai

Country China

Sectors Collaborations & Partnerships- R&D, Collaborations & Partnerships-Licensing, Collaborations & Partnerships-Manufacture, Drug Delivery, Proprietary Research & Manufacture

Website Visit Website

Map Open Google Maps

Company Activities

Founded in 2023 and based in Shanghai, China, Allink Biotherapeutics is a biotech company dedicated to expediting the development of a diverse pipeline of FIC/BIC therapeutic candidates for oncology and immune diseases. Our goal is to harness our proprietary bispecific antibody and ADC technology platforms, along with efficient execution and business collaboration , to address critical unmet clinical needs.

Sectors

Collaborations & Partnerships- R&D

Collaborations & Partnerships-Licensing

Collaborations & Partnerships-Manufacture

Drug Delivery

Proprietary Research & Manufacture

Category/Key Word(s)

Biologics

Precision Therapeutics

Bioconjugation

Antibody Drug Conjugates

Platform Technology-Drug Discovery

Platform Technology-Drug Development

Drug Conjugates & Linkers

Antibodies-Bi-specific-Multi-specific

Drug Delivery Technology

Clinical Development-Pipeline

Tumour Targeting

immuno-oncology

Oncology Products

Anti-Cancer Products

Company Contacts

No key contacts have been added to this profile yet.

Company Reviews

No reviews have been added to this profile yet.

Claim This Profile

This is the company profile page for Allink Biotherapeutics on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.

Quick Actions

Save Company Give a Referral Print Profile

Overview Partnerships News Financials Media Locations Blogs